Take the three self-paced courses at no cost through the NVIDIA Deep Learning Institute (DLI).
Take the three self-paced courses at no cost through the NVIDIA Deep Learning Institute (DLI).
Categories
AI Agents Are Here. What Now?
In the rapidly evolving landscape of artificial intelligence, the quality of the data used for training models is paramount. High-quality data ensures that…
In the rapidly evolving landscape of artificial intelligence, the quality of the data used for training models is paramount. High-quality data ensures that models are accurate, reliable, and capable of generalizing well across various applications. The recent NVIDIA webinar, Enhance Generative AI Model Accuracy with High-Quality Multimodal Data Processing, dove into the intricacies of data…
In the webinar on January 28th, you’ll get an inside look of the new GPU engine to learn how Polars’ declarative API and query optimizer enable seamless GPU…
In the webinar on January 28th, you’ll get an inside look of the new GPU engine to learn how Polars’ declarative API and query optimizer enable seamless GPU acceleration.
Organizations are increasingly turning to accelerated computing to meet the demands of generative AI, 5G telecommunications, and sovereign clouds. NVIDIA has…
Organizations are increasingly turning to accelerated computing to meet the demands of generative AI, 5G telecommunications, and sovereign clouds. NVIDIA has unveiled the DOCA Platform Framework (DPF), providing foundational building blocks to unlock the power of NVIDIA BlueField DPUs and optimize GPU-accelerated computing platforms. Serving as both an orchestration framework and an implementation…
NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and pioneering advanced healthcare services with agentic and generative AI.
IQVIA, the world’s leading provider of clinical research services, commercial insights and healthcare intelligence, is working with NVIDIA to build custom foundation models and agentic AI workflows that can accelerate research, clinical development and access to new treatments. AI applications trained on the organization’s vast healthcare-specific information and guided by its deep domain expertise will
Read Article
Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization….
Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization. Adapting these specialized models to new tasks requires substantial time, computational power, and expertise—challenges that grow when researchers simultaneously work across multiple targets or properties.
Designing a therapeutic protein that specifically binds its target in drug discovery is a staggering challenge. Traditional workflows are often a painstaking…
Designing a therapeutic protein that specifically binds its target in drug discovery is a staggering challenge. Traditional workflows are often a painstaking trial-and-error process—iterating through thousands of candidates, each synthesis and validation round taking months if not years. Considering the average human protein is 430 amino acids long, the number of possible designs translates to…
For decades, leadership in computing and software ecosystems has been a cornerstone of American strength and influence worldwide. The federal government has wisely refrained from dictating the design, marketing and sale of mainstream computers and software — key drivers of innovation and economic growth. The first Trump Administration laid the foundation for America’s current strength
Read Article